
1. malar j. 2020 jun 5;19(1):201. doi: 10.1186/s12936-020-03281-x.

prevalence mutations plasmodium falciparum chloroquine resistance
transporter, pfcrt, association ex vivo susceptibility common
anti-malarial drugs african plasmodium falciparum isolates.

foguim ft(1)(2)(3), bogreau h(1)(2)(3), gendrot m(1)(2)(3), mosnier
j(1)(2)(3)(4), fonta i(1)(2)(3)(4), benoit n(1)(2)(3)(4), amalvict r(1)(2)(3)(4),
madamet m(1)(2)(3)(4), wein s(5), pradines b(6)(7)(8)(9); french national
reference centre imported malaria study group.

collaborators: augis v, bastien p, benoit-vical f, berry a, brouqui p, chauvin p,
cividin m, courtier f, delaunay p, delhaes l, drancourt m, dubosc n, gaillard t, 
genin a, garnotel e, javelle e, l'ollivier c, lagier jc, ledault e, leveque m,
malvy d, marty p, ménard g, menu e, millet p, minodier p, parola p, picot s,
pomares-estran c, ranque s, receveur mc, robin a, sappa e, savini h, sevestre j, 
simon f, sterkers y, surcouf c, varlet e, wolff a.

author information: 
(1)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, ihu méditerranée
infection, 19-21 boulevard jean moulin, 13005, marseille, france.
(2)aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france.
(3)ihu méditerranée infection, marseille, france.
(4)centre national de référence du paludisme, marseille, france.
(5)laboratory pathogen host interactions, umr 5235, cnrs-université de
montpellier, montpellier, france.
(6)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, ihu méditerranée
infection, 19-21 boulevard jean moulin, 13005, marseille, france.
bruno.pradines@gmail.com.
(7)aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france.
bruno.pradines@gmail.com.
(8)ihu méditerranée infection, marseille, france. bruno.pradines@gmail.com.
(9)centre national de référence du paludisme, marseille, france.
bruno.pradines@gmail.com.

background: plasmodium falciparum chloroquine transporter gene (pfcrt) is
known involved chloroquine amodiaquine resistance, more
particularly mutations loci 72 76 localized within second exon.
additionally, new mutations (t93s, h97y, c101f, f145i, m343l, c350r g353v)
were recently shown associated vitro reduced susceptibility to
piperaquine asian south american p. falciparum strains. however, few
data available prevalence mutations effect on
parasite susceptibility anti-malarial drugs, particularly piperaquine
in africa.
methods: molecular investigation mutations performed 602
african p. falciparum parasites collected 2017 2018 malaria
patients hospitalized france travel african countries. associations
between genotypes vitro susceptibilities piperaquine standard
antimalarial drugs assessed.
results: none mutations, previously described associated with
piperaquine resistance, found 602 p. falciparum african isolates. 
k76t mutation associated resistance chloroquine (p < 0.0002) and
desethylamodiaquine (p < 0.002) africa. k76t mutation associated
with vitro reduced susceptibility piperaquine. mutation i356t,
identified 54.7% (n = 326) african isolates, significantly
associated reduced susceptibility quinine (p < 0.02) increased
susceptibility mefloquine (p < 0.04). k76t i356t mutations were
significantly associated west african isolates (p = 0.008).
conclusion: none mutations pfcrt found associated with
piperaquine reduced susceptibility asia south america (t93s, h97y, c101f,
f145i, m343l c350r g353v) found 602 african isolates including
the three isolates reduced susceptibility piperaquine. k76t mutation,
involved resistance chloroquine amodiaquine, i356t mutation
were associated vitro reduced susceptibility piperaquine.
differences mefloquine susceptibility i356 356t isolates were,
while statistically different, minimal. analyses needed more
important sample size geographic area confirm role the
i356t mutation quinine susceptibility.

doi: 10.1186/s12936-020-03281-x 
pmcid: pmc7275453
pmid: 32503540 

